PlainRecalls
FDA Drug Moderate Class II Ongoing

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05

Reported: October 29, 2025 Initiated: October 9, 2025 #D-0034-2026

Product Description

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05

Reason for Recall

Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

Details

Recalling Firm
USV Private Limited
Units Affected
8,952 bottles
Distribution
Nationwide within the United States
Location
Dabhel, Daman

Frequently Asked Questions

What product was recalled?
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05. Recalled by USV Private Limited. Units affected: 8,952 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 29, 2025. Severity: Moderate. Recall number: D-0034-2026.